The TDRD7 antibody is a polyclonal antibody targeting the C-terminal region of Tudor domain-containing 7 (TDRD7), a protein encoded by the TDRD7 gene in humans and Tdrd7 in mice. This antibody is widely used in research to study TDRD7’s roles in antiviral immunity, RNA granule regulation, and lens development .
Key applications include:
TDRD7 inhibits viral replication (e.g., HSV-1, Sendai virus) by blocking AMP-activated protein kinase (AMPK), a kinase required for autophagy. Key findings:
Knockout models: TDRD7−/− cells show increased viral DNA and ICP0 protein expression .
AMPK interaction: TDRD7 binds AMPK’s auto-inhibitory domain via its Tudor domain .
TDRD7 regulates RNA granules in lens cells:
Cataract-linked mutations: TDRD7 mutations destabilize crystallin mRNAs (e.g., Crybb3, Hspb1) .
RNA granule dynamics: TDRD7 knockdown reduces stress granule formation in lens cells .
Mouse models: Tdrd7 knockout mice exhibit increased AMPK activation and susceptibility to respiratory viruses .
Lung pathology: Enhanced viral replication in Tdrd7−/− mice correlates with severe lung inflammation .
While the TDRD7 antibody is critical for studying viral restriction and lens biology, gaps remain:
STRING: 7955.ENSDARP00000101927
TDRD7 is a scaffold protein that functions in multiple cellular processes. It is a component of cytoplasmic RNA granules involved in post-transcriptional regulation of specific genes through binding to specific mRNAs and regulating their translation . TDRD7 is required for lens transparency during development by regulating translation of genes such as CRYBB3 and HSPB1 . Recently, TDRD7 was identified as an antiviral interferon-stimulated gene (ISG) that inhibits viral replication by interacting with AMPK and interfering with the autophagy pathway . Mutations in TDRD7 can cause congenital cataracts and male infertility, highlighting its importance in both lens development and spermatogenesis .
TDRD7 contains multiple tudor domains that enable interaction with methylated proteins. In humans, the canonical protein has 1098 amino acid residues with a molecular mass of approximately 123.6 kDa . TDRD7 is predominantly localized in the cytoplasm and is found in specific ribonucleoprotein (RNP) complexes such as chromatoid bodies in spermatids (called processing bodies or P-bodies in somatic cells) . It forms complexes with several proteins including TDRD1, TDRD6, DDX4, CABLES1, PCTK2, and PIWIL1 . TDRD7 has been shown to interact with histone H3 tri-methylated at K9 in vitro, suggesting potential roles in chromatin regulation .
TDRD7 antibodies are utilized in multiple research applications as outlined in the table below:
To investigate TDRD7's role in RNA regulation, a comprehensive approach combining several methodologies is recommended:
RNA Immunoprecipitation (RIP): Use TDRD7 antibodies to isolate TDRD7-RNA complexes. Research shows TDRD7 directly binds to mRNAs such as Hspb1 and Crybb3 . The RIP protocol should include:
Crosslinking of RNA-protein complexes
Immunoprecipitation with TDRD7-specific antibodies
RNA isolation and analysis by RT-qPCR or RNA sequencing
Comparison with IgG control immunoprecipitations
Knockdown/knockout validation: TDRD7 depletion experiments reveal its post-transcriptional regulatory functions:
Polysome profiling: Evidence shows TDRD7 affects translation efficiency:
Recent research identified TDRD7 as an interferon-stimulated gene with antiviral activity . To study this function:
AMPK interaction analysis:
Functional validation using knockout models:
Viral infection assays:
Track viral load by qPCR and immunohistochemistry
Compare viral replication in wild-type versus TDRD7-deficient cells/tissues
Measure AMPK phosphorylation status using phospho-specific antibodies
Rescue experiments:
Re-expression of TDRD7 in knockout cells restores normal AMPK regulation
Inhibition of AMPK can potentially rescue the antiviral phenotype
TDRD7 mutations cause congenital cataracts in humans . To investigate this function:
Protein expression analysis:
RNA-regulatory mechanism studies:
Developmental expression patterns:
Immunohistochemistry with TDRD7 antibodies tracks expression during lens development
Co-staining with lens fiber cell markers reveals temporal-spatial patterns
Morphological analysis:
Western blotting for TDRD7 requires specific considerations due to its high molecular weight (~123.6 kDa) :
Sample preparation:
Use RIPA buffer with protease inhibitors for efficient extraction
For testicular tissue, special attention to RNase inhibitors is important if studying TDRD7-RNA complexes
Gel and transfer parameters:
Use 8% SDS-PAGE gels for better resolution of high molecular weight proteins
Transfer at lower voltage (30V) overnight at 4°C for efficient transfer of large proteins
Antibody selection and dilution:
Expected results:
Immunoprecipitation using TDRD7 antibodies has been crucial in identifying its protein interactions (AMPK) and RNA targets (HSPB1, LINE1) :
Lysis conditions optimization:
For protein interactions: Use mild detergents (0.5-1% NP-40) to preserve complexes
For RNA immunoprecipitation: Include RNase inhibitors and use formaldehyde crosslinking
Antibody selection and validation:
Controls for RIP experiments:
TDRD7 functions as an RNA-binding protein in regulating translation of specific targets :
RNA immunoprecipitation protocol optimization:
Analysis of translational regulation:
RNA granule visualization:
Recent research has identified TDRD7's role in autophagy regulation :
Mechanistic pathway:
Experimental approaches:
Physiological relevance:
TDRD7 plays a role in retrotransposon silencing, particularly LINE1 elements in the male germline :
Translational regulation mechanism:
Interaction with piRNA pathway:
Experimental approaches:
RNA stability assays using DRB treatment
Transcription rate analysis using 5-ethynyluridine incorporation
Immunoprecipitation to detect TDRD7-LINE1 RNA associations
Analysis of translation factors binding to LINE1 RNA
TDRD7 is a component of RNA granules and affects their formation and function :
Stress granule formation assays:
RNA granule component analysis:
Immunoprecipitation with TDRD7 antibodies followed by mass spectrometry
Co-localization studies with canonical stress granule and P-body markers
RNA content analysis of TDRD7-containing granules
Functional rescue experiments:
Re-expression of wild-type TDRD7 in knockdown/knockout cells
Domain mutant analysis to identify regions required for granule association
Multiple bands in TDRD7 Western blots can result from:
Isoform detection: Up to 3 different TDRD7 isoforms have been reported
Proteolytic degradation: TDRD7's large size makes it susceptible to degradation during sample preparation
Post-translational modifications: TDRD7 may undergo modifications that alter its migration pattern
Cross-reactivity: Some antibodies may recognize related tudor domain proteins
To address these issues:
Use freshly prepared samples with complete protease inhibitors
Validate with TDRD7 knockout/knockdown controls
Try multiple antibodies targeting different epitopes of TDRD7
For thorough validation of TDRD7 antibodies:
Genetic controls:
Recombinant protein controls:
Application-specific controls: